Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Inspiolto in hyperinflated COPD patients
NCT03425617Phase 4Completed
- Sponsor
- Queen's University
- Start
- Jan 2017
- Primary completion
- Jun 2018
- Modality
- Inhalation Devices, Small Molecules
- Countries
- 1
01
Overview
A Phase 4 trial of tiotropium + olodaterol in chronic obstructive pulmonary disease (COPD), sponsored by Queen's University. Started Jan 2017; status: completed.
02
Drugs
tiotropium + olodaterol
03
Conditions
chronic obstructive pulmonary disease (COPD)
Beyond the preview
Go deeper on NCT03425617.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03425617.